Tag Archives: digital-marketing

Make the Most of JPM Week with Sunday Partnering at the Marriott Marquis 

21 Oct

By Max Braht, Director of Business Development, LSN

Max-Braht-Headshot

JPM week is coming fast, and the best opportunities go to those who plan early. If you still haven’t secured a venue or partnering space, Life Science Nation (LSN) has your solution. As the host of RESI JPM, LSN is opening Sunday partnering at the Marriott Marquis, giving attendees an extra day to meet face-to-face with fellow RESI participants or connect informally outside the partnering system before the main event begins.

Sunday partnering provides a head start on the biggest week in healthcare investment, whether you’re scheduling investor meetings, gathering your team, or hosting your own private event. The Marriott Marquis is at the center of the JPM ecosystem, making it the perfect base for receptions, showcases, and partnering tables throughout the week.

If you represent a membership organization, this is your chance to give your members valuable exposure and a convenient home base in San Francisco—without the steep prices other hotels are charging for table rentals. And for product or service providers, sponsoring or exhibiting at RESI remains the most direct and cost-effective way to meet early-stage innovators. Unlike other partnering events, RESI’s community welcomes vendor meetings, and our partnering stats show that clearly.

Life Science Nation is here to help you make the most of the biggest week of the year. Whether you’re planning a private reception, setting up a partnering table, or joining RESI as an exhibitor, our team can help you build visibility, secure meetings, and connect with the early-stage life science community that gathers at JPM each January.

Register RESI JPM by Friday, October 24 to save $600 on early bird rates!

Register for RESI JPM >>

LSN Ecosystem Deal Matrix $1.29 Billion and Counting 

15 Oct

By Dennis Ford, Founder & CEO, Life Science Nation (LSN)

DF-News-09142022Across Life Science Nation (LSN)’s interconnected network, from the Investor & Licensing Partner Database and RESI Conference Series to LSN Labs, 90 companies have publicly disclosed raising capital or signing licensing deals sourced directly through LSN.  LSN has been collecting this disclosed data and, after reaching 90 deals, wanted to extrapolate the compelling metrics behind the LSN engine that facilitated the deals, known as the LSN Ecosystem.

Together, they’ve secured $1.29 billion in verified funding. When factoring in the broader global community of 9,000+ startups that have engaged with LSN tools and programs and gone through the RESI turnstiles, the estimated impact reaches $6.4 billion. This isn’t modeled data; these are real companies, real partners, and real outcomes. It’s proof that structured global partnering delivers measurable success.

A Marketplace That Works — and Scales

At first glance, the dataset lists 90 companies and 52 investors. On closer inspection, that ratio reflects how healthy marketplaces behave. Each transaction represents multiple funding relationships, roughly 100 to 150 discrete deals in total, many of which are undisclosed but very much real.

  • For startups, closing $1.29 billion through LSN-facilitated partnerships signals one of the strongest verified conversion rates in early-stage life sciences.
  • For investors, repeat participation by six global funds, including corporate venture, pharma, and family offices, demonstrates a growing cycle of trust and sourcing efficiency within LSN’s ecosystem.

This is not a collection of introductions; it’s a living marketplace where structure, data, and discipline transform intro meetings into ongoing dialogue, building relationships that ultimately lead to transactions.

Where the Money Moves: The Four Domains (4Ds)

SECTOR DISCLOSED FUNDING ($) % SHARE COMMENT
Drugs (Therapeutics) 1,106,490,000 83% Core growth engine for global biotech
Devices (Medtech) 120,820,000 9% Strategic investments and exits rising
Diagnostics & Tools 111,330,000 8% A precision frontier gaining traction
Digital Health Emerging (<1%) Expanding rapidly as AI matures and the software moves adroitly

Therapeutics dominate the dollars, but the deal flow is distributed, indicating a balanced and resilient early-stage market that spans drugs, devices, diagnostics, and digital health alike.

Even Distribution, Uneven Costs

It’s no surprise that therapeutics absorb most of the capital; drug development is costly and front-loaded. A single preclinical or IND-enabling round can match the combined raises of multiple device or diagnostics startups. But when you look at deal volume, not just deal size, the picture changes. The 90 funded companies are evenly distributed across the 4Ds:

SECTOR  COMPANIES FUNDED  SHARE OF TOTAL 
Drugs (Therapeutics)  31 34%
Diagnostics & Tools  26 29%
Devices (Medtech)  23 26%
Digital Health  10 11%

The big money may flow into drugs, but the deals are happening across all four domains. That balance defines a healthy market, diversified, dynamic, and alive.

Average Deal Size Across the 4Ds

SECTOR  AVERAGE RAISE PER COMPANY ($)  INSIGHT 
Drugs (Therapeutics)  $35.7 million Reflects the high capital intensity of preclinical and early clinical development
Devices (Medtech)  $5.3 million Medtech investors focus on de-risked prototypes and regulatory progress
Diagnostics & Tools  $4.3 million Enabling and precision technologies attract steady, mid-range funding
Digital Health  >$3 million Early but fast-growing; deal sizes expected to rise with data maturity

These numbers capture a simple truth: Drug rounds dominate in size, but early-stage innovation thrives across every domain. The LSN ecosystem delivers results across all four, not just where the biggest checks are written.

The Signal: Efficiency Is the New Advantage

As global capital tightens, efficiency wins. With RESI London (Dec 2025) and RESI JPM (Jan 2026) approaching, startups and investors alike are leaning into systems that don’t just connect, they convert. LSN’s rhythm of data, readiness, and disciplined outreach has become the commercialization backbone for early-stage life sciences worldwide.  “At RESI, we don’t chase headlines; we measure outcomes. The companies and investors in this dataset are the proof.”

Join the Momentum. Be Part of the Data.

The next cycle begins now. Don’t miss your chance to access the world’s most effective life science partnering platform.

Registration now open:

  • RESI London 2025 (Dec. 4, 8&9) – [Register]
  • RESI JPM 2026 (Jan.12-14, 19&20)– [Register]
  • RESI Europe 2026 (March 23-25) – [Register]

Host Your JPM Reception, Presentation, Showcase or Partnering at the Marriott Marquis 

15 Oct

By Matt Stanton, VP Sales US West, Central and South America, LSN

JPM is creeping up on you once again, and you still don’t have an event planned. All the good venues are gone and all you’re left with are subprime ones or those with sky-high prices. Why not work with us to plan your best event or partnering table rental at the centrally located Marriott Marquis? RESI JPM will be a two-day event this year: Monday and Tuesday. Life Science Nation has rental space available on Sunday, that will allow you to put your event during what is already a lively ecosystem of early-stage companies and investors. If you already have an event planned, why not do more? If there were ever a time to do more, it’s during JPM.

If you’re a membership organization, you owe it to your members to provide them partnering space at JPM. But getting a partnering table at one of the San Fran hotels will costs at least $1500 per day per table! Contact us to find out how you can get conveniently located partner tables for your members at affordable prices.

Finally, if you’re a product or service provider, sponsoring, exhibiting or attending RESI is, by far, the best opportunity to bang out 50+ meetings with early-stage innovators. RESI is the only partnering conference where companies are more than happy to accept partnering meetings with vendors, as can be seen in our partnering stats. In the RESI partnering system, you won’t find any profiles with the dreaded “no service provider requests”. Additionally, sponsoring or exhibiting at RESI is less than doing so at any of the other main JPM conferences.

See you at JPM!

Secure Your RESI JPM Exhibitor Spot Contact Us to Reserve Event Space

LSN Staff on Global Event Circuit; Find Out Who, What, and Where

30 Sep

By Max Braht, Director of Business Development, LSN

Max-Braht-Headshot

Life Science Nation is on the move. Between now and RESI London, our team will be attending a series of leading life science and medtech conferences around the world, connecting with innovators, investors, and strategic partners. Getting out into the global ecosystem allows us to better understand emerging trends, foster collaborations, and support life science companies in reaching their fundraising and partnership goals.

These engagements also reinforce the value of our global conference, RESI, which brings together investors, entrepreneurs, and strategic partners from across the world to drive innovation in life sciences. Attending regional and international events helps us strengthen these connections and grow our global community.

Here’s where you can find our team in the coming months:

October 
Oct. 4–8: San Diego for the MedTech conference, engaging with medical device innovators and investors. San Diego, CA
  • Max Braht (m.braht@lifesciencenation.com)
  • Matt Stanton (m.stanton@lifesciencenation.com)
Oct. 4–8: LSN Bootcamp and BioSpain, connecting with early-stage life science companies. Barcelona, Spain
  • Greg Mannix (g.mannix@lifesciencenation.com)
  • Karen Deyo (k.deyo@lifesciencenation.com)
  • Brenda Olmos (b.olmos@lifesciencenation.com)
Oct. 8–10: Japan for BioJapan, focusing on international biotech partnerships. Yokohama, Japan
  • Dennis Ford (dford@lifesciencenation.com)
  • Claire Jeong (c.jeong@lifesciencenation.com)
  • Momo Yamamoto (m.yamamoto@lifesciencenation.com)
Oct. 21-23: Sao Paulo for Corporate Venture in Brazil 2025, highlighting innovation and investment opportunities in Latin America. Sao Paulo, Brazil
  • Dennis Ford (dford@lifesciencenation.com)
  • Max Braht (m.braht@lifesciencenation.com)
  • Matt Stanton (m.stanton@lifesciencenation.com)
Oct 24-25: Washington DC for the 9th Annual KAPAL Conference, meeting global leaders in biotech and healthcare. Washington DC
  • Sougato Das (s.das@lifesciencenation.com)
Oct. 27–28: Miami for the BioHunt Summit, meeting emerging life science startups and investors. Miami, FL
  • Dennis Ford (dford@lifesciencenation.com)
  • Matt Stanton (m.stanton@lifesciencenation.com)
November 
Nov. 2–6: Vienna for BioEurope, connecting with corporate and venture partners across the life science ecosystem. Vienna, Austria
  • Max Braht (m.braht@lifesciencenation.com)
  • Greg Mannix (g.mannix@lifesciencenation.com)
Nov. 12–14: Malta at the MedTech World Summit, exploring opportunities in medical technology. Valletta, Malta
  • Greg Mannix (g.mannix@lifesciencenation.com)
  • Brenda Olmos (b.olmos@lifesciencenation.com)
Nov. 16–20: London for Jefferies London Life Sciences Week, engaging with global investors and biotech innovators. London, UK
  • Max Braht (m.braht@lifesciencenation.com)
  • Greg Mannix (g.mannix@lifesciencenation.com)
December 
Dec. 2: France for Biofit/Medfit, meeting early-stage innovators and strategic partners in biotech and medtech. Strasbourg, France
  • Max Braht (m.braht@lifesciencenation.com)
  • Matt Stanton (m.stanton@lifesciencenation.com)

We look forward to seeing our community at these events. If you’d like to connect with us while we’re on the road, please reach out to resi@lifesciencenation.com

Life Science Nation and The Ganesha Lab Launch a Global Two-Way Innovation Bridge Connecting South America, Anchored in São Paulo, Brazil, to the International Healthcare Arena 

23 Sep

By Dennis Ford, Founder & CEO, Life Science Nation (LSN)

DF-News-09142022São Paulo, Brazil – September 23, 2025 – In a landmark move to expand Latin America’s role in the global life sciences sector, Life Science Nation (LSN) and The Ganesha Lab (TGL), Latin America’s premier life sciences scale-up platform, announce a strategic alliance to launch a dedicated bricks-and-mortar accelerator hub in São Paulo by the end of 2025.

Uniting Global Scale with Local Depth

The São Paulo-based facility will serve as the Latin American anchor node of LSN’s global partnering backbone, a system of affiliated tech hubs, economic development agencies, incubators, and accelerators worldwide, all connected through LSN’s two-way innovation bridge model.

This new effort builds upon years of development work with leading Brazilian stakeholders, including Abiquifi and ApexBrasil, alongside local governments, universities, and innovation agencies, as well as service providers, to ensure the hub will be fully integrated into Brazil’s national strategy for life sciences by both LSN and TGL.

  • The Ganesha Lab brings regional depth: through its BigInBIO scale-up platform, TGL sources and mentors startups, delivers structured readiness programs, builds an alumni base across Latin America, and maintains strong relationships with CROs, universities, governments, and pharma partners. As LSN’s anchor partner for Latin America, TGL provides the credibility and local integration that enable the bridge to function.
  • Life Science Nation brings global reach: as the architect of the two-way innovation bridge, LSN provides a commercialization-first partnering backbone that includes its curated 4,000-profile investor and licensing partner database, AI-driven readiness assessments, BD Assist outbound campaign execution, and the five annual RESI investor conferences worldwide, where more than 400 companies have raised over $5B.

Tangible, Two-Way Impact

  • Outbound: Building on TGL’s BigInBIO platform, Latin American startups will be mentored and readied regionally, then advanced into LSN Labs’ commercialization-first global roadshow process, narrative refinement, global target list creation, CRM-driven outreach, and full integration into international RESI conferences.
  • Inbound: Global life sciences technologies, investors, and licensing partners will be brought into Brazil through LSN’s ecosystem, leveraging TGL’s local networks to accelerate collaboration, validation, and market entry.
  • Capital & Partnering Alliances: International investors and licensing partners from LSN’s global network will syndicate with Brazilian VCs, corporates, and pharma, expanding capital access and helping local partners build a global footprint.

Together, TGL and LSN create a seamless pathway: from regional readiness → to global campaign execution → to inbound technologies and capital integrating into Latin America. The São Paulo accelerator will serve as the anchor node for Latin America in LSN’s global partnering backbone.

Accelerator Operations and Ecosystem Collaborations

A newly formed Brazilian team will operate the São Paulo accelerator, working with new and existing partners from local government, top universities, regional innovation agencies, and service providers. The accelerator will act as a permanent node, building local capacity while embedding Latin America into the global life sciences economy.

“We are committed to powering innovation in both directions, helping Latin American startups scale globally and enabling global innovators to leverage Brazil’s unique advantages,” said Dennis Ford, Founder & CEO of Life Science Nation.

“Together, we are creating an innovation bridge that not only builds businesses but also strengthens Brazil’s role as the leading gateway for life sciences innovation in Latin America,” said Markus Schreyer, Founder & CEO of The Ganesha Lab.

“LSN has built a precision matching and meeting connection engine for over a decade, helping more than 400 companies raise $5B. Anchoring the accelerator in Brazil will strengthen the LATAM market and connect the region directly into LSN’s global backbone. The time is right to bring Latin America into the network and expand its global life science footprint,”  said Matt Stanton, LSN’s VP of LATAM Business Development.

The program is targeting going live by the end of 2025 or early 2026. The São Paulo hub will be the first of its kind in Latin America, with the potential to replicate across other innovation centers in the region, further embedding Latin America into the global life sciences economy.

The partnership will also be highlighted at the upcoming BioHunt Summit 2025 in Miami, where Dennis Ford and Markus Schreyer will hold a fireside chat to expand on the announcement.

About Life Science Nation (LSN)

Life Science Nation (LSN), founded by Dennis Ford, is a global leader in connecting early-stage life science companies with capital investors and licensing partners. LSN owns and operates the LSN Investor & Licensing Partner Database (4,000 curated profiles), the Redefining Early-Stage Investments (RESI) Conference Series (five global partnering events annually), and the LSN Newsletter (60,000 global readers), alongside podcasts and published works such as The Life Science Executive’s Fundraising Manifesto.

Through its accelerator arm, LSN Labs, LSN has pioneered the two-way innovation bridge model, a partnering backbone that affiliates with tech hubs, incubators, accelerators, and economic development agencies worldwide. This model enables regions, patient groups, and nonprofits to aggregate technology assets, launch them outbound into global markets, and simultaneously bring inbound capital, licensing partners, and technologies into their ecosystems. Over the past decade, LSN has helped more than 400 companies raise over $5 billion through global roadshow campaigns and partnering events.

About The Ganesha Lab (TGL)

The Ganesha Lab (TGL), founded by Markus Schreyer, is Latin America’s premier life sciences scale-up platform. Through its flagship program BigInBIO, TGL provides structured readiness programs, mentoring, and founder development for biotech and health startups. Selected companies may also receive investment support, with TGL maintaining long-term engagement for three years or more post-program through its alumni network.

With strong ties to CROs, universities, governments, and pharma across the region, TGL plays a vital role in sourcing and nurturing the most promising science-based ventures in Latin America, preparing them for international scale-up and investment. TGL’s proven regional expertise and credibility make it the ideal anchor partner for launching the São Paulo accelerator and establishing Latin America as a key node in the global life sciences economy.

Explore the RESI Boston September 2025 Program Guide 

9 Sep

By Dennis Ford, Founder & CEO, Life Science Nation (LSN)

DF-News-09142022The official program guide for RESI Boston, September 2025 is now available! Redefining Every Stage of Investment (RESI) is designed to connect life science and healthcare innovators with a global network of investors across diverse funding strategies, from Seed through Series B and beyond.

This guide provides a complete overview of what to expect throughout the conference, detailing the content and layout for our in-person event on September 17th. Inside, you’ll find the full agenda, speaker bios, panel descriptions, and essential information to help you navigate your RESI experience. Whether you’re participating in investor meetings, the Innovator’s Pitch Challenge, workshops, or ad hoc networking, this guide is your resource to stay organized and maximize your time at RESI Boston.

Access the full guide here:

Register for RESI Boston

FREE Pre-RESI Event: Structuring Your Startup: Legal, Tax, Funding, and Strategic Decisions

3 Sep

By Max Braht, Director of Business Development, LSN

Max-Braht-Headshot

Life Science Nation (LSN) invites early-stage life science and healthcare companies to a free, in-person pre-conference event designed to equip founders and executives with the knowledge and tools to build a successful venture in the U.S. market.

Structuring Your Startup: Legal, Tax, Funding, and Other Strategic Decisions will be held on Tuesday, September 16, from 1:00–5:00 PM at CIC Cambridge, Havana Room, One Broadway, Cambridge, MA. Taking place the day before RESI Boston 2025 (September 17–19), this workshop is a valuable opportunity for companies in town for Biotech Week Boston to gain practical insights and make new connections.

Attendees will hear from leading organizations, including Polsinelli, Eva Garland, LabCentral, Savills, and EisnerAmper, along with LSN, on the critical decisions that shape an emerging life science company. Topics will span legal frameworks, risk mitigation, tax considerations, fundraising approaches, deal structuring, operational planning, and pathways for life science companies entering or looking to scale within the U.S. market.

The program also features time dedicated to networking, giving founders and executives the chance to connect with peers, advisors, and potential partners before the RESI conference begins.

This pre-conference session is part of LSN’s ongoing effort to support life science entrepreneurs in landing their companies in the Boston innovation ecosystem and expanding into the U.S. market.

Registration is free, but space is limited. Don’t miss your chance to join.